Delcath Systems (DCTH) Revenue Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Delcath Systems | 383.27 Mn | 293.95 Mn | 21.26 Mn | 247.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 247.23% |
| Dec 31, 2025 | 218.92% |
| Sep 30, 2025 | 183.13% |
| Jun 30, 2025 | 211.79% |
| Mar 31, 2025 | 274.06% |
| Dec 31, 2024 | 82.09% |
| Sep 30, 2024 | 345.11% |
| Jun 30, 2024 | 169.22% |
| Mar 31, 2024 | 129.11% |
| Dec 31, 2023 | -12.15% |
| Sep 30, 2023 | 51.02% |
| Jun 30, 2023 | 23.62% |
| Mar 31, 2023 | 71.67% |
| Dec 31, 2022 | 4.13% |
| Sep 30, 2022 | 76.78% |
| Jun 30, 2022 | 60.99% |
| Mar 31, 2022 | 28.06% |
| Dec 31, 2021 | 45.21% |
| Sep 30, 2021 | -46.38% |
| Jun 30, 2021 | -22.59% |
| Mar 31, 2021 | -28.09% |
| Dec 31, 2020 | 4.14% |
| Sep 30, 2020 | -43.10% |
| Jun 30, 2020 | -23.45% |
| Mar 31, 2020 | -45.85% |
| Dec 31, 2019 | -5.75% |
| Sep 30, 2019 | -27.76% |
| Jun 30, 2019 | -27.97% |
| Mar 31, 2019 | -21.35% |
| Dec 31, 2018 | -94.56% |
| Sep 30, 2018 | 27.35% |
| Jun 30, 2018 | 22.57% |
| Mar 31, 2018 | 16.50% |
| Dec 31, 2017 | 34.24% |
| Sep 30, 2017 | 46.62% |
| Jun 30, 2017 | 32.51% |
| Mar 31, 2017 | 33.83% |
| Dec 31, 2016 | 1.95% |
| Sep 30, 2016 | 82.13% |
| Mar 31, 2016 | 65.92% |
| Dec 31, 2015 | 29.96% |
| Sep 30, 2015 | 117.09% |
| Jun 30, 2015 | 63.82% |